UBS Maintains Buy on AdaptHealth, Lowers Price Target to $9
Benzinga Newsdesk 3 hours ago
Analyst RatingsNewsPrice Target
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $10 to $9.
UBS analyst Kevin Caliendo maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $10 to $9.